Latest Insider Transactions at Fulgent Genetics, Inc. (FLGT)
This section provides a real-time view of insider transactions for Fulgent Genetics, Inc. (FLGT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Fulgent Genetics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Fulgent Genetics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2021
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
10,358
-6.03%
|
$745,776
$72.94 P/Share
|
|
May 20
2021
|
John C Bolger Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+48.48%
|
-
|
|
May 20
2021
|
Linda Marsh |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+50.0%
|
-
|
|
May 20
2021
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,000
-0.29%
|
$74,000
$74.48 P/Share
|
|
May 18
2021
|
Hanlin Gao Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
315
-0.04%
|
$22,050
$70.71 P/Share
|
|
May 18
2021
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,155
-0.67%
|
$80,850
$70.71 P/Share
|
|
May 18
2021
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
931
-0.27%
|
$65,170
$70.71 P/Share
|
|
May 01
2021
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
504
-0.15%
|
$38,808
$77.02 P/Share
|
|
Apr 30
2021
|
Hanlin Gao Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+0.43%
|
-
|
|
Mar 15
2021
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.87%
|
$312,000
$104.1 P/Share
|
|
Mar 09
2021
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
62,000
-15.22%
|
$6,324,000
$102.65 P/Share
|
|
Mar 09
2021
|
John C Bolger Director |
SELL
Open market or private sale
|
Direct |
3,374
-96.43%
|
$340,774
$101.62 P/Share
|
|
Mar 09
2021
|
John C Bolger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,124
+40.06%
|
$12,496
$4.87 P/Share
|
|
Mar 01
2021
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
403
-0.23%
|
$44,733
$111.38 P/Share
|
|
Feb 27
2021
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
403
-0.1%
|
$40,703
$101.26 P/Share
|
|
Feb 15
2021
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
303
-0.04%
|
$48,783
$161.09 P/Share
|
|
Feb 15
2021
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
806
-0.2%
|
$129,766
$161.09 P/Share
|
|
Feb 15
2021
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,109
-0.64%
|
$178,549
$161.09 P/Share
|
|
Feb 01
2021
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
504
-0.12%
|
$69,048
$137.91 P/Share
|
|
Dec 21
2020
|
Paul Kim CFO and Treasurer |
SELL
Bona fide gift
|
Direct |
100
-0.06%
|
-
|
|
Dec 14
2020
|
Jian Xie President and COO |
SELL
Bona fide gift
|
Direct |
22,500
-5.21%
|
-
|
|
Dec 10
2020
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
16,958
-8.85%
|
$864,858
$51.94 P/Share
|
|
Dec 09
2020
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
10,662
-5.27%
|
$543,762
$51.6 P/Share
|
|
Dec 02
2020
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
29,949
-6.47%
|
$1,347,705
$45.86 P/Share
|
|
Dec 02
2020
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,000
-0.23%
|
$46,000
$46.0 P/Share
|
|
Dec 01
2020
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,000
-0.23%
|
$45,000
$45.16 P/Share
|
|
Nov 30
2020
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
3,396
-0.39%
|
$146,028
$43.38 P/Share
|
|
Nov 23
2020
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
6,000
-1.35%
|
$264,000
$44.08 P/Share
|
|
Nov 20
2020
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,000
-0.23%
|
$42,000
$42.5 P/Share
|
|
Nov 18
2020
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.67%
|
$132,000
$44.83 P/Share
|
|
Nov 17
2020
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
3,706
-0.41%
|
$166,770
$45.03 P/Share
|
|
Nov 17
2020
|
John C Bolger Director |
SELL
Open market or private sale
|
Direct |
4,269
-91.93%
|
$187,836
$44.24 P/Share
|
|
Nov 17
2020
|
John C Bolger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,631
+36.16%
|
$0
$0.38 P/Share
|
|
Nov 17
2020
|
Hanlin Gao Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
301
-0.04%
|
$13,545
$45.45 P/Share
|
|
Nov 17
2020
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
3,767
-0.8%
|
$169,515
$45.45 P/Share
|
|
Nov 16
2020
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
100,000
-29.77%
|
$4,600,000
$46.17 P/Share
|
|
Nov 01
2020
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
504
-0.11%
|
$16,128
$32.53 P/Share
|